Sasaki I, Tanaka K, Fujita T, Murakami M, Yamamoto A, Muranishi S
Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd., Shizuoka, Japan.
Biol Pharm Bull. 1995 Jul;18(7):976-9. doi: 10.1248/bpb.18.976.
Intestinal absorption characteristics of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue, were studied in rats by means of in situ closed loop and in vitro everted sac experiments. Plasma concentrations of azetirelin obtained in the in situ closed loop experiments were not significantly different among the intestinal segments. Area under the plasma concentration-time curve (AUC) of azetirelin following administration into the duodenal loop increased in proportion to the dose. The serosal to mucosal concentration ratio of the analogue in the everted sac experiment was constant over the mucosal drug concentration range of 0.01-10 mM. There was no directional difference in the transfer rate of azetirelin across the everted and non-everted sacs of the duodenum. Furthermore, its transport across the duodenum was not influenced by low incubation temperature (25 degrees C), addition of dipeptide (Gly-Gly), or pretreatment of the mucosal surface with 2,4-dinitrophenol, while that of TRH was inhibited under these conditions. These results suggest that the intestinal absorption mechanism of azetirelin is different from that of TRH, and that azetirelin is predominantly transported via a passive diffusion.
通过原位闭环和体外外翻肠囊实验,在大鼠中研究了新型促甲状腺激素释放激素(TRH)类似物阿泽替林的肠道吸收特性。在原位闭环实验中,各肠段获得的阿泽替林血浆浓度无显著差异。十二指肠环给药后阿泽替林的血浆浓度-时间曲线下面积(AUC)与剂量成正比增加。在体外外翻肠囊实验中,该类似物的浆膜与粘膜浓度比在粘膜药物浓度0.01-10 mM范围内保持恒定。阿泽替林穿过十二指肠外翻和未外翻肠囊的转运速率没有方向性差异。此外,其穿过十二指肠的转运不受低孵育温度(25℃)、添加二肽(甘氨酸-甘氨酸)或用2,4-二硝基苯酚预处理粘膜表面的影响,而在这些条件下TRH的转运受到抑制。这些结果表明,阿泽替林的肠道吸收机制与TRH不同,且阿泽替林主要通过被动扩散转运。